Showing results (291-300 of 401) with videos related to
Sort By:
Pageof 41
Annals of Surgical Oncology|April 21, 2021
Arm Morbidity After Local Therapy for Young Breast Cancer PatientsAnne Kuijer, Laura S Dominici, Shoshana M Rosenberg, et al.Breast (Edinburgh, Scotland)|August 20, 2017
ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3)Shani Paluch-Shimon, Olivia Pagani, Ann H Partridge, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2019
Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast CancerPhilip D Poorvu, Shari I Gelber, Shoshana M Rosenberg, et al.Journal of Oncology Practice|March 19, 2015
Outcomes and satisfaction after delivery of a breast cancer survivorship care plan: results of a multicenter trialSteven C Palmer, Carrie Tompkins Stricker, SarahLena L Panzer, et al.NPJ Breast Cancer|August 21, 2024
Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502Daniel G Stover, Roberto Salgado, Oleksander Savenkov, et al.Breast Cancer Research and Treatment|June 10, 2024
Second primary non-breast cancers in young breast cancer survivorsBessie X Zhang, Kristen D Brantley, Shoshana M Rosenberg, et al.Future Oncology (London, England)|October 12, 2021
Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancerCiara C O'Sullivan, Karla V Ballman, Linda McCall, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2018
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused UpdateNeelima Denduluri, Mariana Chavez-MacGregor, Melinda L Telli, et al.Radiology|January 10, 2023
Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in SituDanalyn Byng, Samantha M Thomas, Christel N Rushing, et al.NPJ Breast Cancer|April 16, 2024
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancerStefania Morganti, Qingchun Jin, Julie Vincuilla, et al.Pageof 41